Biotechnology M&A » By The Online Investor Staff, updated Thu., May. 9, 9:46 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
Slide #66. Illumina, Inc. — Verinata Health
Acquirer: |
Illumina, Inc. (NASDAQ:ILMN) |
Acquiree: |
Verinata Health |
Details: |
Illumina, Inc. (NASDAQ:ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina. |
Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services enable the adoption of genomic solutions in research and clinical settings. Co.'s principal products, services, and technologies are: sequencing, which includes Deoxyribonucleic acid (DNA) sequencing, a process of determining the order of nucleotide bases (A, C, G, or T) in a DNA sample; arrays, which are used for a range of DNA and RNA analysis applications; consumables, which Co. has developed various library preparation and sequencing kits; and services, which provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
ILMN SEC Filing Email Alerts Service
Open the ILMN Page at The Online Investor »
Company Name: |
Illumina Inc |
Stock buyback: |
ILMN buyback |
Website: |
www.illumina.com |
Sector: |
Biotechnology |
Number of ETFs Holding ILMN: |
102 |
Total Market Value Held by ETFs: |
$3.13B |
Total Market Capitalization: |
$18.95B |
% of Market Cap. Held by ETFs: |
16.52% |
|
Open the ILMN Page at The Online Investor (in a new window) »
|
May 9, 2024 9:46 AM Eastern
Buy (2.78 out of 4)
16th percentile
|
|